HCW Biologics Inc. (HCWB)
Last updated: 2026-10-22 07:03:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
HCW Biologics Inc. (HCWB) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.17, with a market capitalization of $2.62M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.14 to $24.42. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$2.62M | |
$1.17 | |
$1,866.00 | |
$1.14 | |
$1.17 | |
48.54K | |
416.33K | |
-- | |
$24.42 | |
$1.14 | |
-- | |
-- |
HCW Biologics Inc. (HCWB) Latest Closing Stock Price
HCW Biologics Inc. (HCWB) last closed at $1.17 as of 2026-10-21 23:31:00, unchanged from the previous close of $1.17.
During the latest regular trading session, HCWB traded between $1.14 and $1,866.00, with a volume of 48.54K shares. The closing price was near the lower end and near the lower end of its 52-week range.
HCW Biologics Inc. (HCWB) 7-Day Stock Price Change
Over the past seven days, HCW Biologics Inc. (HCWB) moved from $1.26 to $1.17, representing a decline of 7.14% ($0.09).
The stock traded between $1.14 and $1.45 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 367.31 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
HCWB 52-Week Price Position
Position in Range: 0.1%
HCWB is currently trading at $1.17, placing it 0.1% of the way from its 52-week low of $1.14 to its 52-week high of $24.42. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is HCW Biologics Inc. (HCWB)?
HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.
HCW Biologics Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 35 |
| Exchange | NASDAQ |
| Company Website |
How to Buy HCW Biologics Inc. (HCWB) Stock on MEXC
Eligible investors can buy real shares of HCW Biologics Inc. (HCWB) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is HCW Biologics Inc. (HCWB) stock price today?
2.Is HCWB stock going up or down today?
3.What is HCWB pre-market price?
4.What is HCWB after-hours price?
5.Is HCWB stock trading now?
6.Where does HCWB sit relative to its 52-week high and low?
7.What sector is HCW Biologics Inc. in?
8.What is HCW Biologics Inc.'s market capitalization and where is it listed?
9.How is HCWB valued in terms of P/E ratio and EPS?
10.Does HCW Biologics Inc. pay a dividend?
Explore More US Stocks
Search Stocks
HCWB Stock Calculator
Estimate the value between HCWB shares and USD.
HCWB Shares to USD
1.00 HCWB shares = 1.17 USD
Calculations are estimates based on the latest available price and are for reference only.


